Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Charles, Ruetsch"'
Autor:
Joshua N. Liberman, Tigwa Davis, Dawn Velligan, Delbert Robinson, William Carpenter, Chris Jaeger, Heidi Waters, Charles Ruetsch, Felicia Forma
Publikováno v:
Psychiatric Research and Clinical Practice, Vol 4, Iss 2, Pp 61-70 (2022)
Objective To understand perspectives of mental health care providers regarding barriers and drivers of adopting a medication ingestible event monitoring (IEM) system in clinical practice. Methods Between April and October 2019, a cross‐sectional, o
Externí odkaz:
https://doaj.org/article/9a48fe7bd2c64ef29bcb71d4460aa56a
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Individuals with schizophrenia are a vulnerable and under-served population who are also at risk for severe morbidity and mortality following COVID-19 infection. Our research was designed to identify factors that put individuals w
Externí odkaz:
https://doaj.org/article/7c9efde2f0dc4be5823275677ca8f21b
Autor:
Joshua N. Liberman, Sandipan Bhattacharjee, Pinyao Rui, Charles Ruetsch, Brian Rothman, Amit Kulkarni, Felicia Forma
Publikováno v:
Health Services Research & Managerial Epidemiology, Vol 9 (2022)
Objective To estimate the impact COVID-19 pandemic on healthcare resource utilization (HCRU) among individuals with major depressive disorder (MDD). Method A retrospective cohort study was conducted to compare HCRU in the twelve months prior to and s
Externí odkaz:
https://doaj.org/article/278cf1ffd6164ab7b3dd50d057a5f02e
Autor:
Charles Ruetsch, Joshua N. Liberman, Tigwa H. Davis, Martha Sajatovic, Dawn I. Velligan, Emily K. Wiggins, Felicia Forma
Publikováno v:
Journal of Affective Disorders Reports, Vol 9, Iss , Pp 100344- (2022)
Background: Adherence to antipsychotic medications is critical for treatment and relapse prevention in serious mental illness. Accurate assessment of medication adherence can be difficult, clinicians frequently overestimate patient adherence, and new
Externí odkaz:
https://doaj.org/article/cfce40a85bac484481629ba32b801d9a
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 23:327-335
Autor:
Neel Shah, Fulton F. Velez, Samuel Colman, Laura Kauffman, Charles Ruetsch, Kathryn Anastassopoulos, Yuri Maricich
Publikováno v:
Advances in Therapy. 39:4146-4156
Autor:
Fulton F. Velez, Kathryn P. Anastassopoulos, Samuel Colman, Neel Shah, Laura Kauffman, Sean M. Murphy, Charles Ruetsch, Yuri A. Maricich
Publikováno v:
Advances in Therapy. 39:4131-4145
reSET-O, an FDA-authorized prescription digital therapeutic (PDT) delivering cognitive behavioral therapy and contingency management to patients with opioid uRetrospective analysis of healthcare claims data compared all-cause HCRU (across hospital fa
Publikováno v:
Thursday, April 27.
Autor:
Charles Ruetsch, Tigwa Davis, Joshua N Liberman, Dawn I Velligan, Delbert Robinson, Chris Jaeger, William Carpenter, Felicia Forma
Publikováno v:
Neuropsychiatric Disease and Treatment
Charles Ruetsch,1 Tigwa Davis,1 Joshua N Liberman,1 Dawn I Velligan,2 Delbert Robinson,3 Chris Jaeger,4 William Carpenter,5 Felica Forma6 1Health Analytics, LLC, Columbia, MD, USA; 2Department of Psychiatry, University of Texas Health Science Center
Autor:
Charles Ruetsch, Sam Colman, Kathryn Anastassopoulos, Laura Kauffman, Yuri A. Maricich, Fulton Velez
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Fulton F Velez,1 Sam Colman,2 Laura Kauffman,2 Charles Ruetsch,3 Kathryn Anastassopoulos,2 Yuri A Maricich1 1Pear Therapeutics, Inc., Boston, MA, USA; 2Covance Market Access, Gaithersburg, MD, USA; 3Health Analytics, Columbia, MD, USACorrespondence: